杨 悦近年来,我国创新药发展速度加快,市场规模超过1000亿元。在创新药中,与传统小分子药相比,生物药品发展势头更迅猛。国内生物药品企业在免疫肿瘤药品、基因治疗与细胞治疗、抗体药物等方面取得一定进展。产业发展,政策要跟上。自2015年国务院印发《关于改革药品医疗器械审评审批制度的意见》以来,我国医药产业逐步从仿制药向创新药转型,审评审批积压、创新药上市滞后等问题逐步解决。去年7月,国务院常务会议...
Source Link杨 悦近年来,我国创新药发展速度加快,市场规模超过1000亿元。在创新药中,与传统小分子药相比,生物药品发展势头更迅猛。国内生物药品企业在免疫肿瘤药品、基因治疗与细胞治疗、抗体药物等方面取得一定进展。产业发展,政策要跟上。自2015年国务院印发《关于改革药品医疗器械审评审批制度的意见》以来,我国医药产业逐步从仿制药向创新药转型,审评审批积压、创新药上市滞后等问题逐步解决。去年7月,国务院常务会议...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.